Rapid Diagnostics for Venomous Bites and Toxin-Mediated Diseases

VenomAid develops rapid diagnostic tests that help clinicians and veterinarians identify envenoming faster, enabling better treatment decisions and improving outcomes.

LEARN HOW

About Us

VenomAid is a medtech company at the forefront of revolutionizing snakebite care on a global scale by pioneering affordable diagnostics to reach previously neglected populations.

+++++++++++++++++++++

////////////////////////////

Our resolve to bring about change was born from the urgency to bring snakebite care into the 21st century. Snakebite envenoming remains one of the world's most neglected tropical diseases, affecting millions annually and claiming over 100,000 lives.

By developing affordable technologies that can support clinical decision-making, we're committed to making snakebite care more accessible, efficient, and life-saving.

2023-12-13 VenomAid Lab Work-35_edited.jpg

++++++++++++++++++++++++++++++

■

//////////////////////////////////////////////

positive result

blood sample

SIMPLE, AFFORDABLE, AND DEPLOYABLE

Rapid Snake Venom Detection

Rapid test for detection of
snake venom in clinical samples at the Point of Care

Meet the Team

Our team is an ensemble of scientists, entrepreneurs, and visionaries who have dedicated their careers to advancing the frontiers of snakebite envenoming research.

Jonas Arnold Jürgensen

Co-founder & CEO

Gert Tomczyk

Chairman of the board

Chris Somerville

Board observer, Open Philanthropy

Jesper Kihl

Advisor

Gina Ross

CTO

Andreas Laustsen-Kiel

Co-founder and board member

Heather Youngs

Board observer, Open Philanthropy

Pelle Knudsen

Research Scientist

Morten Munk

Board member

Jens Bøegh

Advisor

Selma Belfakir

Industrial PhD student

Mads Laustsen

Board member

Henrik Harboe

Advisor

Snakebite in numbers

2.7M

ENVENOMINGS

100K+

DEATHS

400T

DISFIGUREMENTS

+5B$

LOST IN GDP$

PUBLICATIONS

We strive to advance the boundaries of science but also address critical knowledge gaps in the realm of snakebite envenoming.

MULTIPLEX LATERAL FLOW ASSAY DEVELOPMENT FOR SNAKE VENOM DETECTION IN BIOLOGICAL MATRICES

Scientific Reports

A novel monoclonal antibody-based lateral flow assay distinguishes Bothrops and Lachesis venoms within 15 minutes, offering a practical solution for point-of-care snakebite diagnosis in Brazil
The lateral flow assay allows rapid, naked-eye or smartphone assisted quantitative detection of Bothrops and Lachesis venoms in plasma and urine, with a limit of detection of 10-50 ng/mL in spiked plasma and urine, aand 50-500 ng/mL in spiked sera.
This holds potential for improved diagnostic precision and patient outcomes in snakebite cases

LIFE FOUNDATION PARTNERSHIP

Educational project together with LIFE foundation, titled FIGHT THE BITE

In Fight the Bite, students must investigate how antibodies can be used to both diagnose and treat snakebite envenomation.

Free course targeting htx and stx in the subject biology B in Denmark
Disposable materials for the course will be delivered at your high school
The duration of the course is three modules of 90 min.

AS FEATURED ON

Rapid Diagnostics for Venomous Bites and Toxin-Mediated Diseases

About Us

Rapid Snake Venom Detection

Meet the Team

Snakebite in numbers

PUBLICATIONS

LIFE FOUNDATION PARTNERSHIP

CONTACT US